IL1B and pulmonary hypertension: Inhibition of PKM2 can reverse the glycolysis status of the hypertensive pulmonary arterial wall (PH-Fib), reduce its cell proliferation, and decrease the expression of IL-1β in macrophages, thus delaying the progression of pulmonary hypertension (56).